Is lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Schizophrenia is a devastating neuropsychiatric disorder of unknown etiology. There is general agreement in the scientific community that schizophrenia is a disorder of neurodevelopmental origin in which both genes and environmental factors come together to produce a schizophrenia phenotype later in life. The challenging questions have been which genes and what environmental factors? Although there is evidence that different chromosome loci and several genes impart susceptibility for schizophrenia; and epidemiological studies point to broad aspects of the environment, only recently there has been an interest in studying gene × environment interactions. Recent evidence of a potential association between prenatal lead (Pb2+) exposure and schizophrenia precipitated the search for plausible neurobiological connections. The most promising connection is that in schizophrenia and in developmental Pb2+ exposure there is strong evidence for hypoactivity of the N-methyl-d-aspartate (NMDA) subtype of excitatory amino acid receptors as an underlying neurobiological mechanism in both conditions. A hypofunction of the NMDA receptor (NMDAR) complex during critical periods of development may alter neurobiological processes that are essential for brain growth and wiring, synaptic plasticity and cognitive and behavioral outcomes associated with schizophrenia. We also describe on-going proof of concept gene-environment interaction studies of early life Pb2+ exposure in mice expressing the human mutant form of the disrupted in schizophrenia 1 (DISC-1) gene, a gene that is strongly associated with schizophrenia and allied mental disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Parvalbumin neurons and gamma rhythms enhance cortical circuit performance
Sohal, V. S., Zhang, F., Yizhar, O., & Deisseroth, K. (2009) · Nature · doi:10.1038/nature07991 · Cited by 2,606 · cited 1×
“The GABAergic-PV+ interneurons in the cerebral cortex are also important for oscillation synchronization of pyramidal cells (Sohal et al., 2009).”
BackgroundCortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297 · cited 1×
“…brain samples from schizophrenia patients suggest that dysfunction of cortical GABAergic interneurons, in particular those containing the calcium-binding protein parvalbumin (PV), may be a core feature of the working memory deficits in schizophrenia (Lewis et al., 2005; Uhlhaas and Singer, 2010).”
BackgroundDopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Abnormal neural oscillations and synchrony in schizophrenia
Uhlhaas, P. J., & Singer, W. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2774 · Cited by 2,120
Intellectual Impairment in Children with Blood Lead Concentrations below 10 μg per Deciliter
Canfield, R. L., Henderson, C. R., Cory-Slechta, D. A., Cox, C., Jusko, T. A., & Lanphear, B. P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022848 · Cited by 2,081
Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain
Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L., & Olney, J. W. (1999) · Science · doi:10.1126/science.283.5398.70 · Cited by 2,055
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
The environment and schizophrenia
van Os, J., Kenis, G., & Rutten, B. P. F. (2010) · Nature · doi:10.1038/nature09563 · Cited by 1,572 · cited 1×
“Genes and Environment: Etiological factors in Schizophrenia The etiology of schizophrenia is not currently known, although there is strong evidence that genetic and environmental factors contribute to the expression of the disease (Tsuang, 2000; van Os et al., 2010; Brown, 2011).”
BackgroundLaruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291 · cited 1×
“…models of schizophrenia have provided evidence of hyperactivity of the dopaminergic system, with an apparent selectivity to the mesolimbic and mesocortical pathways (Laurelle et al., 1996; Abi-Dargham et al., 1998; Harrison, 1999; Lindstram et al., 1999; Pearlson, 2000; Thaker and Carpenter, 2001).”
BackgroundDisruption of two novel genes by a translocation co-segregating with schizophrenia
Millar, J. K. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1415 · Cited by 1,254 · cited 2×
“Mutant DISC1 is the hypothetical protein product of a balanced chromosomal translocation [t(1;11)] in a Scottish pedigree with high load of major mental disorders (LOD=7.1 for all mental disorders and 3.6 for schizophrenia) [Millar et al., 2000a; Millar et al., 2001; Brandon and Sawa, 2011].”
BackgroundInfluentialMice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia
Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H. (1999) · Cell · doi:10.1016/s0092-8674(00)81972-8 · Cited by 1,075
Glia-Derived d-Serine Controls NMDA Receptor Activity and Synaptic Memory
Panatier, A., Theodosis, D. T., Mothet, J.-P., Touquet, B., Pollegioni, L., Poulain, D. A., & Oliet, S. H. R. (2006) · Cell · doi:10.1016/j.cell.2006.02.051 · Cited by 934
Seeman, P., & Lee, T. (1975) · Science · doi:10.1126/science.1145194 · Cited by 869 · cited 1×
“Subsequent studies showed that the therapeutic value of antipsychotic drugs was mediated by blocking D2-dopamine receptors (Seeman and Lee, 1975; Creese et al., 1976; Snyder, 1981).”
BackgroundStrategy for Investigating Interactions Between Measured Genes and Measured Environments
Moffitt, T. E., Caspi, A., & Rutter, M. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.5.473 · Cited by 784 · cited 2×
“Disrupted in Schizophrenia 1 (DISC1) and early life Pb2+ exposure: A proof of concept gene-environment interaction study There is evidence that understanding schizophrenia is likely to come from gene-environment interaction studies (Moffitt et al., 2005; Van Os et al., 2008; Brandon and Sawa, 2011).”
BackgroundPostnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
Belforte, J. E., Zsiros, V., Sklar, E. R., Jiang, Z., Yu, G., Li, Y., Quinlan, E. M., & Nakazawa, K. (2010) · Nature Neuroscience · doi:10.1038/nn.2447 · Cited by 752
van Os, J., Rutten, B. P., & Poulton, R. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn117 · Cited by 713
The environment and susceptibility to schizophrenia
Brown, A. S. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.09.003 · Cited by 664
Disrupted-In-Schizophrenia 1 Regulates Integration of Newly Generated Neurons in the Adult Brain
Duan, X., Chang, J. H., Ge, S., Faulkner, R. L., Kim, J. Y., Kitabatake, Y., Liu, X.-B., Yang, C.-H., Jordan, J. D., Ma, D. K., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.010 · Cited by 611 · cited 1×
“Numerous investigations have implicated DISC1 and interacting proteins in neuronal differentiation, migration, synaptogenesis and adult neurogenesis in the hippocampus [Kamiya et al., 2005; Duan et al., 2007; Brandon, 2007; Faulkner et al., 2008; Brandon et al., 2009].”
BackgroundKetamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase
Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585 · cited 1×
“This is supported by evidence from rodent and non-human primate studies that administration of NMDAR antagonists decreases GAD67 and PV expression in cortical GABAergic interneurons (Cochran et al., 2003; Behrens et al., 2007; Morrow et al., 2007).”
ResultGlutamatergic mechanisms in schizophrenia
Tsai, G., & Coyle, J. T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082701.160735 · Cited by 577 · cited 4×
“The hippocampus is part of the limbic system involved in learning and memory and it is a principal brain region affected in schizophrenia (Tsai and Coyle, 2002; Konradi and Heckers, 2003) and in Pb2+ neurotoxicity (Krigman et al 1974; Petit and LeBoutillier, 1979; Winder et al 1983; Guilarte and…”
BackgroundResultInfluentialBehavioral phenotypes of Disc1 missense mutations in mice
Clapcote, S. J., Lipina, T. V., Millar, J. K., Mackie, S., Christie, S., Ogawa, F., Lerch, J. P., Trimble, K., Uchiyama, M., Sakuraba, Y., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.04.015 · Cited by 526
A Possible Role for the Striatum in the Pathogenesis of the Cognitive Symptoms of Schizophrenia
Simpson, E. H., Kellendonk, C., & Kandel, E. (2010) · Neuron · doi:10.1016/j.neuron.2010.02.014 · Cited by 478
Decreased Brain Volume in Adults with Childhood Lead Exposure
Cecil, K. M., Brubaker, C. J., Adler, C. M., Dietrich, K. N., Altaye, M., Egelhoff, J. C., Wessel, S., Elangovan, I., Hornung, R., Jarvis, K., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050112 · Cited by 458 · cited 3×
“…1) it provides additional support that in vivo, Pb2+ behaves as a potent NMDAR antagonist, and 2) it shows that Pb2+ exposure in early life enhances apoptotic cell death and this effect may help explain the loss in brain volume documented in Pb2+-exposed children later in life (Cecil et al., 2008).”
BackgroundInfluentialWoo, T.-U. W., Walsh, J. P., & Benes, F. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.649 · Cited by 411
Beneyto, M., Kristiansen, L. V., Oni-Orisan, A., McCullumsmith, R. E., & Meador-Woodruff, J. H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301312 · Cited by 408
Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1
Hayashi-Takagi, A., Takaki, M., Graziane, N., Seshadri, S., Murdoch, H., Dunlop, A. J., Makino, Y., Seshadri, A. J., Ishizuka, K., Srivastava, D. P., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2487 · Cited by 399
Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment
Konradi, C., & Heckers, S. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00328-5 · Cited by 336 · cited 3×
“…is part of the limbic system involved in learning and memory and it is a principal brain region affected in schizophrenia (Tsai and Coyle, 2002; Konradi and Heckers, 2003) and in Pb2+ neurotoxicity (Krigman et al 1974; Petit and LeBoutillier, 1979; Winder et al 1983; Guilarte and McGlothan,…”
BackgroundResultKinney, J. W., Davis, C. N., Tabarean, I., Conti, B., Bartfai, T., & Behrens, M. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4722-05.2006 · Cited by 329 · cited 2×
“More specifically the activity of NR2A subunit-containing NMDAR have been shown to have an important role in the maintenance of PV and GAD67 protein levels in cultured interneurons (Kinney et al., 2006).”
BackgroundPrenatal interaction of mutant DISC1 and immune activation produces adult psychopathology
Abazyan, B., Nomura, J., Kannan, G., Ishizuka, K., Tamashiro, K. L., Nucifora, F., Pogorelov, V., Ladenheim, B., Yang, C., Krasnova, I. N., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.022 · Cited by 255 · cited 1×
“We propose that in vivo and in vitro models based on genetic mutations with functional effects and measurable relevant environment factors will significantly advance studies of the molecular underpinnings of gene-environment interplay (Ayhan et al., 2009; Abazyan et al., 2010).”
BackgroundSelf-citationSakata, K., Woo, N. H., Martinowich, K., Greene, J. S., Schloesser, R. J., Shen, L., & Lu, B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811431106 · Cited by 200 · cited 2×
“A recent study has shown that BDNF exon IV mutant mice exhibit significant deficits in PV-positive GABAergic interneurons in the prefrontal cortex, an interneuron subtype that has been implicated in working memory/executive function impairment in schizophrenia (Sakata et al., 2009).”
BackgroundUnderstanding the Role of DISC1 in Psychiatric Disease and during Normal Development
Brandon, N. J., Millar, J. K., Korth, C., Sive, H., Singh, K. K., & Sawa, A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3355-09.2009 · Cited by 198 · cited 1×
“Numerous investigations have implicated DISC1 and interacting proteins in neuronal differentiation, migration, synaptogenesis and adult neurogenesis in the hippocampus [Kamiya et al., 2005; Duan et al., 2007; Brandon, 2007; Faulkner et al., 2008; Brandon et al., 2009].”
BackgroundKocsis, B. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.002 · Cited by 159
Kolomeets, N. S., Orlovskaya, D. D., Rachmanova, V. I., & Uranova, N. A. (2005) · Synapse · doi:10.1002/syn.20153 · Cited by 149 · cited 1×
“A more recent observation related to the hippocampus is that Pb2+-exposed rats exhibit reductions in mossy fiber innervation to the CA3 region of the hippocampus (Verina et al., 2007), a finding that has been documented in the brain of schizophrenia subjects (Kolomeets et al., 2005).”
BackgroundAyhan, Y., Abazyan, B., Nomura, J., Kim, R., Ladenheim, B., Krasnova, I. N., Sawa, A., Margolis, R. L., Cadet, J. L., Mori, S., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2009.144 · Cited by 148
Self-citationBrown, L. A., Khousbouei, H., Goodwin, J. S., Irvin-Wilson, C. V., Ramesh, A., Sheng, L., McCallister, M. M., Jiang, G. C. T., Aschner, M., & Hood, D. B. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.05.005 · Cited by 110
Timofeeva, O. A., & Levin, E. D. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.038 · Cited by 74 · cited 1×
“Homomeric nicotinic cholinergic receptors composed of the α7 subunit and those with a α4β2 composition are the most abundantly expressed in the brain and play an important role in memory processes (Ripoll et al., 2004; Timofeeva and Levin, 2011).”
BackgroundRelationships between glutamine, glutamate, and GABA in nerve endings under Pb-toxicity conditions
Strużyńska, L., & Sulkowski, G. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.02.010 · Cited by 74
Cited by
Health consequences of exposure to e-waste: a systematic review
Grant, K., Goldizen, F. C., Sly, P. D., Brune, M.-N., Neira, M., van den Berg, M., & Norman, R. E. (2013) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70101-3 · Cited by 756
Cognitive Impairment Induced by Lead Exposure during Lifespan: Mechanisms of Lead Neurotoxicity
Ramírez Ortega, D., González Esquivel, D. F., Blanco Ayala, T., Pineda, B., Gómez Manzo, S., Marcial Quino, J., Carrillo Mora, P., & Pérez de la Cruz, V. (2021) · Toxics · doi:10.3390/toxics9020023 · Cited by 341
Mechanisms of lead and manganese neurotoxicity
Neal, A. P., & Guilarte, T. R. (2013) · Toxicology Research · doi:10.1039/c2tx20064c · Cited by 211
Self-citationAssociation of lead-exposure risk and family income with childhood brain outcomes
Marshall, A. T., Betts, S., Kan, E. C., McConnell, R., Lanphear, B. P., & Sowell, E. R. (2020) · Nature Medicine · doi:10.1038/s41591-019-0713-y · Cited by 164
Epigenetics of early-life lead exposure and effects on brain development
Senut, M.-C., Cingolani, P., Sen, A., Kruger, A., Shaik, A., Hirsch, H., Suhr, S. T., & Ruden, D. (2012) · Epigenomics · doi:10.2217/epi.12.58 · Cited by 151
Metadata
- Authors
- Guilarte, T. R., Opler, M., & Pletnikov, M.
- Venue
- NeuroToxicology
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 33
- Issue
- 3
- Pages
- 560-574
- ISSN
- 0161-813X (ISSN-L)
- OpenAlex
- W2061598406
- Cited by
- 96
- References
- 38
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.